| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/28/2002 | WO2002016581A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016566A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | WO2002016561A2 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | WO2002016440A2 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | WO2002016437A2 Rhabdovirus-based vectors to express high levels of functional human antibodies |
| 02/28/2002 | WO2002016436A2 ANTIBODIES TO HUMAN IL-1$g(b) |
| 02/28/2002 | WO2002016433A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016432A2 Two receptors of meiosis activating sterols designated sam1a and sam1b |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016419A2 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | WO2002016416A2 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | WO2002016415A2 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | WO2002016414A2 Composition for the elimination of autoreactive b-cells |
| 02/28/2002 | WO2002016409A2 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 02/28/2002 | WO2002016401A2 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 02/28/2002 | WO2002016385A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | WO2002015977A2 Methods and compositions for treating ige-related disease using nnt-1 inhibitors |
| 02/28/2002 | WO2002015941A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual |
| 02/28/2002 | WO2002015932A1 Methods for treating demyelinating diseases |
| 02/28/2002 | WO2002015931A1 Immunologic method for the prevention of dental caries |
| 02/28/2002 | WO2002015920A2 Treatment of hyperproliferative diseases |
| 02/28/2002 | WO2002015846A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/28/2002 | WO2001085779A3 Protein complexes and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001085762A3 Cancer diagnosis and assays for screening anti-cancer agents |
| 02/28/2002 | WO2001081380A3 Immunogenic pneumococcal protein and vaccine compositions thereof |
| 02/28/2002 | WO2001079271A9 Albumin fusion proteins |
| 02/28/2002 | WO2001079258A9 Albumin fusion proteins |
| 02/28/2002 | WO2001078796A9 Type ii gonadotropin-releasing hormone receptor and polynucleotides encoding therefor |
| 02/28/2002 | WO2001075064A3 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 02/28/2002 | WO2001073043A3 32451, a human ubiquitin conjugating enzyme-like molecule and uses thereof |
| 02/28/2002 | WO2001073029A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 02/28/2002 | WO2001070984A3 Anti-tissue factor antibodies with enhanced anticoagulant potency |
| 02/28/2002 | WO2001070255A3 Combined treatment with keratinocyte growth factor and epidermal growth factor inhibitor |
| 02/28/2002 | WO2001068852A3 Apolipoprotein-a-i regulation of t-cell signalling |
| 02/28/2002 | WO2001065998A3 Methods for the diagnosis and treatment of breast cancer |
| 02/28/2002 | WO2001064254A3 Engineered spray-dried lipid-based microparticles for cellular targeting |
| 02/28/2002 | WO2001062895A3 Simultaneous stimulation and concentration of cells |
| 02/28/2002 | WO2001057188A3 Novel nucleic acids and polypeptides |
| 02/28/2002 | WO2001055327A3 Nucleic acids, proteins, and antibodies |
| 02/28/2002 | WO2001053339A3 Egg specific surface proteins |
| 02/28/2002 | WO2001046260A3 Novel immunoglobulin superfamily members apex-1, apex-2 and apex-3 and uses thereof |
| 02/28/2002 | WO2001042474A3 Interferon-like molecules and uses thereof |
| 02/28/2002 | WO2001032702A3 Molecular structure of rhd negative locus |
| 02/28/2002 | WO2001031029A3 Human sphingosine kinase gene |
| 02/28/2002 | WO2000077037A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/28/2002 | WO2000050566A3 Genes encoding insect odorant receptors and uses thereof |
| 02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 02/28/2002 | US20020026044 For treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, psoriasis; for wound healing |
| 02/28/2002 | US20020026040 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases |
| 02/28/2002 | US20020026036 Constructing cassette vector by inserting cDNA coding for heavy chain constant region of human antibody into expression vector for animal cell use, establishing cloning site, digesting cdna coding for heavy chain, inserting into vector |
| 02/28/2002 | US20020025942 Novel tau/neurofilament protein kinases |
| 02/28/2002 | US20020025923 Antiinflammatory agents |
| 02/28/2002 | US20020025559 Nucleotide sequences for use in the diagnosis and treatment of hypertension, heart, and kidney defects |
| 02/28/2002 | US20020025558 Human MAD proteins and uses thereof |
| 02/28/2002 | US20020025551 Novel molecules of the t129-related protein family and uses thereof |
| 02/28/2002 | US20020025550 Methods for producing highly phosphorylated lysosomal hydrolases |
| 02/28/2002 | US20020025543 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 02/28/2002 | US20020025536 Methods and reagents for isolating biologically active antibodies |
| 02/28/2002 | US20020025517 Methods and compositions for cellular and metabolic engineering |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025513 Antigen/antibody specificity exchanger |
| 02/28/2002 | US20020025320 For use in boosting immune response; useful for enhancement of mucosal immune response |
| 02/28/2002 | US20020025319 Antibodies that bind phosphatidyl serine and a method of their use |
| 02/28/2002 | US20020025318 Transferrin-binding proteins from n.gonorrhoeae and n. meningitidis |
| 02/28/2002 | US20020025317 For therapy and prophylaxis of pathological condition associated with expression of Interelukin-12 and/or Interleukin-18, including excessive or inappropriate amounts of those cytokines |
| 02/28/2002 | US20020025316 For promoting the healing of wounds or fibrotic disorders with reduced scarring |
| 02/28/2002 | US20020025315 Chimeric antibodies for delivery of antigens to selected cells of the immune system |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | DE10036469A1 Ultraspiracle (USP)-Protein von Heliothis virescens Ultraspiracle (USP) protein of Heliothis virescens |
| 02/28/2002 | CA2674888A1 Anti-ige vaccines |
| 02/28/2002 | CA2674838A1 Anti-ige vaccines |
| 02/28/2002 | CA2421062A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | CA2420490A1 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/28/2002 | CA2420482A1 Progression suppressed gene 13 (psgen 13) and uses thereof |
| 02/28/2002 | CA2420477A1 Haemophilus influenzae lipopolysaccharide inner-core oligosaccharide epitopes as vaccines for the prevention of haemophilus influenzae infections |
| 02/28/2002 | CA2420261A1 Genes and proteins, and their uses |
| 02/28/2002 | CA2420257A1 Identification of a cam-kinase ii inhibitor |
| 02/28/2002 | CA2420193A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420176A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420140A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420101A1 Kidney-specific protein |
| 02/28/2002 | CA2420086A1 Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies |
| 02/28/2002 | CA2420054A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof |
| 02/28/2002 | CA2419919A1 Novel imidazoline receptor homologs |
| 02/28/2002 | CA2419872A1 Identification of a human n-terminal acetyltransferase gene |
| 02/28/2002 | CA2419840A1 Treatment of hyperproliferative diseases |
| 02/28/2002 | CA2419810A1 Mfq-111, a novel human gtpase like protein |
| 02/28/2002 | CA2419274A1 Methods and compositions for treating ige-related disease using nnt-1 inhibitors |
| 02/28/2002 | CA2419270A1 Monoclonal antibody ds6, tumor-associated antigen ca6, and methods of use thereof |
| 02/28/2002 | CA2417787A1 Lipid metabolism enzymes |
| 02/28/2002 | CA2417186A1 Microtubule-associated proteins and tubulins |
| 02/28/2002 | CA2388061A1 Diagnosis and treatment of cardiovascular conditions |
| 02/28/2002 | CA2356124A1 Anti-ige vaccines |
| 02/27/2002 | EP1182259A1 Pyruvate:NADP+ oxidoreductase and uses thereof |
| 02/27/2002 | EP1182258A1 Mutants of the factor VII activating protease and methods for their detection |
| 02/27/2002 | EP1182256A1 Pollinosis-associated gene 513 |
| 02/27/2002 | EP1182255A1 Genes involved in immune related responses observed with asthma |
| 02/27/2002 | EP1182213A1 Hybrid enzyme and use thereof |
| 02/27/2002 | EP1182212A2 Ultraspiracle USP-protetin of Heliothis virescens |